Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Everest Acquires Global Rights to Protease Inhibitor Therapies for COVID-19

Everest Medicine's mRNA Omicron COVID-19 Vaccine to Start WHO Trials

Everest and Providence Developing Omicron Variant COVID Vaccine

Brii Bio Approved to Launch Combination COVID-19 Therapy in China

CanSinoBIO Signs Deal for Aerosol Delivery of COVID-19 Vaccine

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China